Novus therapeutics, inc. (NVUS)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-19,307

-16,011

-16,441

-17,044

-16,140

-14,065

-11,601

-11,075

-14,548

-13,116

-14,743

-21,043

-27,907

-37,959

-45,239

-47,822

-43,253

-45,087

-40,278

-34,815

-31,709

-23,296

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

9

9

10

10

10

11

12

11

21

22

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of operating lease asset

174

173

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant inducement expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

1,534

1,308

1,805

1,816

1,593

1,543

996

908

634

579

728

1,224

2,086

3,002

3,517

3,675

3,289

2,901

2,633

3,008

2,652

2,108

0

0

0

Depreciation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

171

210

193

157

109

58

31

22

21

0

0

0

Release of reserve for loan to former advisor

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

94

128

147

158

0

0

0

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-115

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

-410

-354

450

344

565

476

-221

-458

332

517

1,140

903

-749

-1,263

-2,191

-1,348

522

958

2,502

2,973

1,401

1,830

0

0

0

Accounts payable and accrued expenses

-1,377

-1,392

-119

323

1,452

1,094

-797

-1,953

-2,154

-1,958

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

-170

-165

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-12,031

-13,857

-15,187

-15,233

-13,645

-11,893

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-778

-766

176

-1,548

443

-237

1,158

2,631

760

0

0

0

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,565

1,551

3,129

1,971

1,476

1,726

681

548

1,274

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

0

0

0

-

-

-

-

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-27,662

-36,520

-38,087

-39,164

-39,872

-41,236

-38,819

-33,033

-27,449

-21,121

0

0

0

Financing activities
Purchase of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

17

233

390

537

565

349

199

58

25

0

0

0

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

35,683

23,464

-8,037

-40,482

-40,510

-40,194

-24,497

-208

-175

0

0

0

Proceeds from issuances of common stock, net

-

9,676

9,677

9,676

107

7,491

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants, net

0

-

-

-

-

-

-

-

-

3,119

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

37

85

273

480

464

420

232

33

16

0

0

0

Net cash provided by financing activities

14,760

9,676

9,677

9,747

178

7,562

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

94

128

147

158

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

400

37

85

273

495

513

6,717

95,464

94,805

94,799

0

0

0

Net change in cash

2,729

-4,181

-5,510

-5,486

-13,467

-4,331

-2,840

-3,392

21,888

16,186

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-800

-14,538

-46,928

-79,859

-81,233

-72,296

37,934

67,148

73,503

0

0

0

Deferred offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0